Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript
Agile Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-0.92.
Agile Therapeutics Inc (AGRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.45 | 50,000 | $22,500.00 | 64,343 | 2022-08-26 | Filing | |
| $0.85 | 5,734,560 | $4,874,376.00 | 21,654,485 | 2021-10-13 | Filing | |
| $0.00 | 58,824 | $0.00 | 285,130 | 2021-10-13 | Filing | |
| $0.00 | 58,824 | $0.00 | 573,734 | 2021-10-13 | Filing | |
| $1.26 | 26,200 | $33,095.84 | 514,910 | 2021-07-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.44 | 760,291 | $334,528.04 | 6,151,110 | 2019-10-29 | Filing | |
| $0.51 | 3,815,349 | $1,945,827.99 | 6,911,401 | 2019-10-28 | Filing | |
| $0.30 | 298,628 | $89,439.09 | 3,231,372 | 2018-07-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
12 Best Biotech Penny Stocks to Invest In
The past few years have been a topsy-turvy ride for the biotech sector.
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Agile Therapeutics Third Quarter 2023 Financial Results Conference Call. Please note, today's event is being recorded.
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Agile Therapeutics Second Quarter of 2023 Financial Results Conference Call. Please note today’s event is being recorded.
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Agile Therapeutics First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome to the Agile Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. Please note, today's event is being recorded.
5 Best Penny Stocks to Buy and Hold According to Reddit
In this article, we will discuss the 5 best penny stocks to buy and hold according to Reddit.
10 Best Penny Stocks to Buy in July
Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential growth potential.
5 Cheap Pharmaceutical Stocks For 2022
Evolus, Inc. (NASDAQ:EOLS) operates as a medical aesthetics firm.
5 Biotech Penny Stocks to Buy Now
Kaleido Biosciences, Inc. (NASDAQ:KLDO) is a clinical-stage healthcare firm that develops microbiome metabolic therapies.
Billionaire Hedge Funds
